Efficacy of combined axitinib with dacarbazine in a B16F1 melanoma xenograft model

In this study, we evaluated the efficacy and intestinal side effects of the selective inhibitor of vascular endothelial growth factor (VEGF) receptors, axitinib and/or dacarbazine (DTIC), in a B16F1 melanoma xenograft model. C57BL/6 mice were subcutaneously inoculated with B16F1 melanoma cells. The...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, XIAO-HUA, QIAO, EN-QI, GAO, ZHENZHEN, YUAN, HUA-QING, CAI, PEI-FEN, LI, XIAO-MIN, GU, YAN-HONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742768/
https://www.ncbi.nlm.nih.gov/pubmed/23946779
http://dx.doi.org/10.3892/ol.2013.1345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742768/
https://www.ncbi.nlm.nih.gov/pubmed/23946779
http://dx.doi.org/10.3892/ol.2013.1345

Ejemplares similares